Mesoblast (MEOBF) Long-Term Deferred Tax (2017 - 2021)

Mesoblast (MEOBF) has disclosed Long-Term Deferred Tax for 5 consecutive years, with $80.2 million as the latest value for Q2 2021.

  • Quarterly Long-Term Deferred Tax rose 1.35% to $80.2 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $80.2 million through Jun 2021, up 1.35% year-over-year, with the annual reading at $80.2 million for FY2021, 1.35% up from the prior year.
  • Long-Term Deferred Tax hit $80.2 million in Q2 2021 for Mesoblast, up from $79.1 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $80.2 million in Q2 2021 to a low of $56.6 million in Q2 2018.
  • Historically, Long-Term Deferred Tax has averaged $71.9 million across 5 years, with a median of $78.2 million in 2017.
  • Biggest five-year swings in Long-Term Deferred Tax: fell 27.68% in 2018 and later rose 20.89% in 2020.
  • Year by year, Long-Term Deferred Tax stood at $78.2 million in 2017, then decreased by 27.68% to $56.6 million in 2018, then increased by 15.65% to $65.4 million in 2019, then increased by 20.89% to $79.1 million in 2020, then grew by 1.35% to $80.2 million in 2021.
  • Business Quant data shows Long-Term Deferred Tax for MEOBF at $80.2 million in Q2 2021, $79.1 million in Q2 2020, and $65.4 million in Q2 2019.